Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
Date:8/16/2010

98,341 Interest (income) expense, net40,895 54,179 EBITDA2,284,044 3,109,482 Adjustments:   Non-cash stock compensation340,242 ,321,445 Adjusted EBITDA $
2,624,286 $
4,430,927 CONFERENCE CALL AND WEBCASTA conference call and live Internet webcast will be held on Monday, August 16, 2010, at 5:00 p.m. Eastern Time to discuss the Company's second quarter 2010 financial results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 800-642-1687 (for U.S. callers) or 706-645-9291 (for international callers). The Conference ID for the rebroadcast is 90510603. The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.

ABOUT CUMBERLAND PHARMACEUTICALSCumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's product portfolio includes Acetadote® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (ibuprofen) Injection, the first injectable treatment for pain and fever available in the United States, and Kristalose® (lactulose) for Oral Solution, a prescription laxative. Cumberland is dedicated to providing innovative products which improve quality of care for patients. For more information on Cumberland Pharmaceuticals, please visit the Company's website at www.cumberlandpharma.com.

ABOUT CALDOLORCaldolor is indicated for the management of mild to moderate pain and management of moderate to severe pain as an adjunct to opioid
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
2. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
3. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
4. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
5. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
6. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
7. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
8. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
9. Ferring Pharmaceuticals FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
10. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
11. Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
(Date:11/26/2014)... 25, 2014 Nanomix Inc., (Nanomix), ... development of mobile diagnostic tests to enable ... and pre-hospital settings, today announced it has ... The certification was awarded by the British ... leading certification bodies. ISO ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2
(Date:11/27/2014)... knows, Cyber Monday is a crazy shopping day. Owing to ... now providing many big promotions on its website. Customers can ... current prices. The discount are up to 80% off. So ... orders above $88) from Dec. 1 – 4 2014. , ... are willing to shop on the internet. As a leading ...
(Date:11/27/2014)... 28, 2014 This is a professional ... global Bronchoscopes industry with a focus on the Chinese ... status of the Bronchoscopes manufacturers and is a valuable ... interested in the industry. , Firstly, the report provides ... applications and manufacturing technology. Then, the report explores the ...
(Date:11/27/2014)... November 27, 2014 Absolute PhysioCare ... recently announced that its personalized treatment plans, highly ... can help victims of sports injuries reach pre-injury ... or patellofemoral pain syndrome, Absolute Physio has the ... jumper’s knee, ACL tears, meniscal injuries, groin strain ...
(Date:11/27/2014)... 2014 Blood-borne pathogens raise the risk ... and procedures in place to counter this. However, it ... things tainted with menstrual blood are taken as seriously. ... more sanitary way to handle tampons and menstrual pads ... Sonora, Calif. , He then created a prototype of ...
(Date:11/27/2014)... -- Most babies and young children don,t need medicines ... Drug Administration says. Over-the-counter (OTC) cold and cough ... 2 because they could cause serious and potentially deadly ... about three colds a year, but children get them ... want to give them pain relievers, decongestants and other ...
Breaking Medicine News(10 mins):Health News:Tidebuy.com Launching Overcoats Sales for the Special Monday in 2014 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:Coquitlam Physiotherapy Clinic Now Helps Clients Reach Pre-Injury State 2Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2
... link, experts say , , TUESDAY, May 27 (HealthDay News) ... day: A new study finds that gum disease could raise ... disease had a 14 percent higher risk of cancer than ... persisted among never smokers," said lead researcher Dominique Michaud, a ...
... D for children is 200 International Units (IUs), but ... safely take ten-times that amount. According to a recently ... Endocrinology & Metabolism (JCEM), this order-of-magnitude increase could improve ... other long-term health benefits. , Our research reveals that ...
... at Seattle Children,s Hospital, Swedish Medical Center and Medical University of South ... ... Ranging from Pediatrics to Cancer ... NEW YORK, May 27 The Doctor,s Channel, (http://www.thedoctorschannel.com ), hailed by ...
... Present on Communicating the Value of ... in Clinical Drug Development, MOUNTAIN VIEW, Calif., ... a leading provider of software, strategic,consulting, and regulatory ... Helen Kastrissios, Ph.D., senior,scientist, Pharsight Strategic Consulting Services, ...
... a partnership between Peninsula Medical School, NHS South ... has been awarded a 20 million grant to ... including heart disease, diabetes, mental illness, childhood disability ... of seven new collaborations between NHS organisations and ...
... available worldwide, WASHINGTON, May 27 ... Schoomaker today announced continued expansion of medical,information ... record,led by the Army. Medical Communications for ... capabilities and access to battlefield medical,information via ...
Cached Medicine News:Health News:Gum Disease Might Boost Cancer Risk 2Health News:Gum Disease Might Boost Cancer Risk 3Health News:Current vitamin D recommendations fraction of safe, perhaps essential levels for children 2Health News:The Doctor's Channel Launches New Videos from Three Top Hospitals 2Health News:The Doctor's Channel Launches New Videos from Three Top Hospitals 3Health News:Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress 2Health News:£20M health research collaboration announced for the southwest England 2Health News:Life-Saving Technology Expands Globally to Military Branches - Transforming the Way Medical Care is Documented on the Battlefield 2
... System is a sterile, pre-shaped, three-dimensional device ... a mesh cylinder to a circular underlay ... unique and innovative design combines the three ... in the repair of inguinal hernias. ,Its ...
... The 800 Series KTP/YAG Surgical Laser ... market. It is a high-power, dual-wavelength ... plastic surgery, orthopedics, general surgery, neurosurgery, ... KTP/532 beam surgically cuts, vaporizes and ...
... a new, portable, light weight, high power ... cosmetic and plastic surgery, general surgery, ENT ... resurfacing, it is the smallest, yet among ... market. It provides an ideal treatment for ...
... Venus-i™ Laser System is a new, portable, ... with applications in dermatology, cosmetic and plastic ... ideal laser for skin resurfacing, it is ... Erbium:YAG lasers on the market. It provides ...
Medicine Products: